SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as investors react to a significant expansion of its partnership with Nvidia, which integrates the QNX operating system into safety-critical edge AI platforms for robotics and industrial applications. The community is actively discussing this as a potential fundamental inflection point, moving beyond the stock's previous meme-status reputation toward a narrative focused on its essential role in the emerging physical AI and software-defined vehicle sectors.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is facing increased volatility and a sharp sell-off following quarterly results that, despite strong revenue growth, featured softer-than-expected guidance and the announcement of a key co-founder's departure. The community remains deeply divided between long-term bulls looking to capitalize on what they perceive as a buying opportunity, and bears expressing concerns over leadership changes, slowing guidance, and broader competitive pressures.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is seeing intense investor focus following a massive 2.8 billion dollar acquisition of Brazil-based Serra Verde, a move the community views as a strategic effort to secure vertical integration and challenge China's supply dominance. While retail sentiment remains polarized between enthusiasm for the company's long-term government-backed prospects and significant skepticism regarding potential dilution, the stock is experiencing high volatility as traders react to positive analyst initiations and aggressive institutional positioning.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is facing intense downward pressure and hitting record lows as investors react to continued share dilution and skepticism surrounding the companys path to profitability. The community remains deeply divided, with some traders betting on a potential short squeeze or buyout, while many others are expressing frustration over management's performance and the stock's persistent freefall.

Newcourt Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Oakland, CA.

Psyence Biomedical Ltd.

Psyence Biomedical is experiencing intense retail interest and volatile price action driven by an executive order to expedite psychedelic drug research. The community is actively debating the stock's potential for a massive short squeeze due to its micro-float, with many participants citing the company's GMP-compliant ibogaine supply chain as a key catalyst while others warn of the risks associated with high-volatility pump-and-dump patterns.

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group (CAR) is surging due to a massive, persistent short squeeze that has left a high percentage of the float shorted and unable to cover, fueling intense community discussion about market manipulation versus genuine momentum. Traders are polarized between retail bulls riding the parabolic climb toward all-time highs and skeptical short-sellers bracing for an eventual, violent mean reversion.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi LLC is facing significant volatility and intense community scrutiny following a sudden leadership shakeup where both the CEO and CFO departed, fueling concerns over transparency and governance. Investors are actively debating whether this transition, paired with the ongoing search for a major anchor tenant for the Matador data center project, represents a structural breakdown or a strategic pivot toward professionalizing the company for future growth.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is surging following a successful Phase 3 trial readout for its psilocybin-based treatment, confirming strong efficacy and safety profiles for treatment-resistant depression. The community is actively debating the stock's potential as a first-mover in the psychedelic space while closely monitoring a new secondary offering that is driving significant volatility and liquidity shifts.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma is currently trending as investors debate the impact of the company's recent rebranding and leadership changes alongside upcoming clinical data. The community is actively discussing the stock's potential as a buyout candidate and debating the significance of the Phase 2 generalized anxiety disorder data readout, with some expressing skepticism over past performance and leadership churn.

Atai Beckley, Inc. is a clinical-stage biopharmaceutical company focused on developing effective, rapid-acting, and convenient mental health treatments. The company is headquartered in New York, NY.

AtaiBeckley Inc.

Atai Life Sciences (ATAI) is gaining significant investor attention driven by an upcoming Phase 3 initiation for its BPL-003 nasal spray and optimism surrounding a potential high-value partnership deal. The community is actively discussing the company's strong cash position, the strategic impact of a U.S. domicile shift, and recent peer-reviewed data highlighting the drug's potential as a scalable treatment for depression.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Harvard Bioscience (NASDAQ:HBIO) Director William Snider Purchases 8,475 Shares

Harvard Bioscience, Inc. (NASDAQ:HBIO - Get Free Report) Director William Snider purchased 8,475 shares of the stock in a transaction dated Tuesday, March 17th. The shares were bought at an average...

Harvard Bioscience (NASDAQ:HBIO) Director Stephen Denelsky Purchases 10,000 Shares

Harvard Bioscience, Inc. (NASDAQ:HBIO - Get Free Report) Director Stephen Denelsky acquired 10,000 shares of Harvard Bioscience stock in a transaction that occurred on Tuesday, March 17th. The shares...

Harvard Bioscience (NASDAQ:HBIO) Director William Snider Acquires 12,525 Shares

Harvard Bioscience, Inc. (NASDAQ:HBIO - Get Free Report) Director William Snider purchased 12,525 shares of the stock in a transaction dated Monday, March 16th. The stock was acquired at an average...

Insider Buying: Harvard Bioscience (NASDAQ:HBIO) Director Purchases 8,475 Shares of Stock

Harvard Bioscience, Inc. (NASDAQ:HBIO - Get Free Report) Director William Snider bought 8,475 shares of the stock in a transaction on Tuesday, March 17th. The stock was purchased at an average price...

John Duke Purchases 5,000 Shares of Harvard Bioscience (NASDAQ:HBIO) Stock

Harvard Bioscience, Inc. (NASDAQ:HBIO - Get Free Report) CEO John Duke bought 5,000 shares of the firm's stock in a transaction on Monday, March 16th. The shares were acquired at an average price of...

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates under the geographical segments: United States, Germany, China, United Kingdom, and Rest of the World. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.

HBIO
Harvard Bioscience Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

HBIOHarvard Bioscience Inc.